The filter of choice: filtration method preference among injecting drug users by Lenneke Keijzer & Elliot Imbert
RESEARCH Open Access
The filter of choice: filtration method preference
among injecting drug users
Lenneke Keijzer* and Elliot Imbert
Abstract
Background: Injection drug use syringe filters (IDUSF) are designed to prevent several complications related to the
injection of drugs. Due to their small pore size, their use can reduce the solution’s insoluble particle content and
thus diminish the prevalence of phlebitis, talcosis.... Their low drug retention discourages from filter reuse and
sharing and can thus prevent viral and microbial infections. In France, drug users have access to sterile cotton
filters for 15 years and to an IDUSF (the Sterifilt®) for 5 years. This study was set up to explore the factors
influencing filter preference amongst injecting drug users.
Methods: Quantitative and qualitative data were gathered through 241 questionnaires and the participation of 23
people in focus groups.
Results: Factors found to significantly influence filter preference were duration and frequency of injecting drug
use, the type of drugs injected and subculture. Furthermore, IDU’s rationale for the preference of one type of filter
over others was explored. It was found that filter preference depends on perceived health benefits (reduced harms,
prevention of vein damage, protection of injection sites), drug retention (low retention: better high, protective
mechanism against the reuse of filters; high retention: filter reuse as a protective mechanism against withdrawal),
technical and practical issues (filter clogging, ease of use, time needed to prepare an injection) and believes (the
conviction that a clear solution contains less active compound).
Conclusion: It was concluded that the factors influencing filter preference are in favour of change; a shift towards
the use of more efficient filters can be made through increased availability, information and demonstrations.
Background
Drug preparations are commonly filtered by illicit drug
users before injection in order to eliminate impurities of
the drug containing solution. Several complications aris-
ing from injecting drug use depend on the characteris-
tics of the filter used [1]. Amongst these is the
introduction of insoluble particles into the blood stream.
Various complications, ranging from minor to severe,
are associated with the intromission of these foreign
bodies. At the site of injection, sterile abscesses, cellu-
lites and ulcers can occur, which increase the risk of
infection at these sites [2,3]. After injection, insoluble
particles such as talc and cellulose will stay intact and
move along with the blood stream, blocking the first
vessels too small to pass. Repeated administration can
thus lead to severe pulmonary and cardiac complications
such as talcosis [4-8]. People suffering from talcosis will
experience moderate to severe dyspnoea, can develop
cyanosis and even die [5,9] This condition can take one
to several years to develop, but once present, the symp-
toms are irreversible and continue to develop despite of
discontinuation of drug use [9]. Poor filtration has been
suggested to be one of the risk factors for the develop-
ment of talcosis [10].
All filters used by injecting drug users (IDUs) will
eliminate some of these particles, but not with the same
efficacy. The size of the majority of insoluble particles
involved in the development of talcosis due to injecting
drug use is within the range of 9 μm to 23 μm (medium
of 14 μm) [11]. Cigarette filters, commonly used by
injecting drug users, eliminate less than half of all parti-
cles above 10 μm [12]. Injecting drug use syringe filters
(IDUSF) have been specifically conceived for drug use
and are capable of eliminating the large majority of
insoluble particles [13]. Three IDUSF are currently* Correspondence: lenneke_keijzer@hotmail.comApothicom, 52 Avenue Edison, Paris, 75013, France
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available: the Compet AG syringe filter (Compet AG,
Switzerland), the “filter syringe” (Frontier Medical
Group, UK) and the Sterifilt® (Apothicom, France).
These IDUSF are not designed to sterilize a non sterile
solution, but to promote single use of filters and to
eliminate particles of over 10 micron, in accordance
with the European Pharmacopeia concerning injectable
preparations. Besides these IDUSF, several commercial
filters called wheel filters are also capable of eliminating
the majority of these particles [14].
Another important characteristic of a filter is its capa-
city to retain drugs, as the retention of a considerable
proportion of the active compound can incite drug
users to hold on to their filter and to reuse it later or
even to share or sell it [15]. The conservation and reuse
of filters puts IDUs at risk of bacterial and fungal infec-
tions, and filter sharing is a known risk factor for hepa-
titis C transmission [16,17]; sharing of paraphernalia
other than syringes might even be a key element in the
ongoing hepatitis C epidemic. IDUSF are specifically
designed to retain as little active compound as possible,
without the necessity to add extra rinses to the filtration
process; this is susceptible to increase their acceptability
and to reduce sharing.
IDUSF can thus substantially reduce some very com-
mon injection related Public Health issues, like the inci-
dence of small vessel blockage and subsequent medical
complications [12,18].
As far as we are aware, France is the only country
where an IDUSF is widely available, and free of charge,
at almost all needle exchange programs (NEPs). These
programs also give out sterile cotton filters (which are
inside a sterile single use cooker given out as a kit, the
Stericup®). IDUs in this country thus have the choice
between two sterile filters. Besides these, some IDU use
cigarette filters; other makeshift filters are rarely used in
France. We describe here a study which explored filtra-
tion method preference by IDUs who have access to
these three options and the influence of the drug being
injected on filter preference. The characteristics of the
Sterifilt® are the following: it eliminates 99% of insoluble
particles, and is additionally effective at shifting the par-
ticle size distribution towards the smaller range, with
approximately 95% of all particles present after filtration
measuring less than 5 μm [12]. This filter retains vir-
tually no drug (0.02 ml), as opposed to cigarette and
makeshift filters which retain about 0.13 ml [13].
Methods
Two complementary methods were used to gather both
quantitative and qualitative information: a questionnaire
and focus groups. A total of 241 questionnaires were
filled in by IDUs visiting 10 different needle exchange
programs in 9 cities in France during 2009. The
questionnaire explored housing, financial resources, fre-
quency of injection, drugs injected during the last
month and details on the last injection: drug injected,
location, type of paraphernalia used and the reasons for
using an IDUSF or not. The responses were collected by
qualified drug workers after a meeting with the study
lead. Focus groups or expert groups were held with the
objective of obtaining detailed qualitative information
on filter preference, drug preparation techniques and
opinions on Sterifilt®. A total of 23 people in 3 different
cities participated in these groups. All participants
injected illicit or pharmaceutical drugs and each
reported having tried the Sterifilt® syringe filter at least
once. Four of the participants had recently quit
injection.
Quantitative analysis was conducted using EpiInfo 6.
The small numbers of people using cigarette filters
obliged us to group these with the cotton filters into
one category: “other filters” as opposed to IDUSF use.
Results and discussion
Participants and drug use
The participants’ main characteristics are briefly
described in table 1. The group of participants under 30
contains more women (40% versus 15%), they inject
more often on a daily basis (74% versus 63%) and use
more heroin (75% versus 45%) and cocaine (66% versus
55%) than their older counterparts. They also live more
frequently with friends and other drug users in unstable
housing and less often have stable resources.
The four drugs or pharmaceuticals most commonly
injected are: buprenorphine (Subutex® and generics),
heroin, cocaine and morphine sulphate (Skénan®) (table
2). The mean number of substances injected during the
last month by individual participants is 2.5.
Cocaine users are slightly younger (median 30 versus
34) and have more precarious living conditions, they
often live in unstable housing and receive low or
unstable financial resources. Morphine and buprenor-
phine users more often inject on a daily basis. The latter
ones have a longer “career” as IDUs (16 years, versus 13
for morphine users and 9 for heroin or cocaine users).
Table 1 Main characteristics of participants
General characteristics Participants






Live in a community of IDUs 14%
Receiving an income or unemployment benefit 22%
Receiving minimum social income
(454,63€ per month)
42%
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Morphine users more frequently experienced a bad hit
during the last 6 months (46% versus 31% for heroin or
cocaine users and 19% for buprenorphine users).
Filtration
The majority of the participants (72%) use the Sterifilt®
on a regular basis ("always” or “frequently”) with at least
one of the substances they injected during the last
month. 25% use this filter regularly with all drugs
injected and 43% have used this filter for their last injec-
tion. When other filters are used, these are cotton filters
in 56% and cigarette filters in 33% of the cases (The
remaining 11%: no filtration, commercial cotton...).
Factors influencing filtration technique preference
Three factors were significantly associated with filter pre-
ference: the individual, the drug injected, and the city.
The syringe filter was used more often by people who
inject frequently (at least 2 to 7 days a week; p < 0.001).
People who started injecting when this filter was already
available were more likely to use it (p = 0.02).
The choice of the type of filter used was highly corre-
lated across drug types for given individuals, suggesting
that people have the tendency to generalise their filtra-
tion technique to all the drugs they inject. However, an
influence of the injected drug remains present: respon-
dents were more likely to filter their buprenorphine
with an IDUSF and their cocaine with another filter
than the other way around.
As for the drugs used during the last injection, we can
distinguish 3 categories amongst the 4 drugs most com-
monly injected in France:
The majority of the buprenorphine injectors (64%)
used an IDUSF. The starch present in these tablets gives
rise to several complications such as the puffy hand syn-
drome. Furthermore, complications at the injection site
are more frequent among buprenorphine injectors [19].
Their reduction seems to be the main motive for Steri-
filt® use among these injectors. This is partly due to the
increased extent of information flow at NEPs on the
injection of buprenorphine tablets and syringe filter use.
A second category includes heroin and cocaine, for
which 39% versus 33% used an IDUSF. The main
argument for using syringe filters is the preservation of
health; their use is facilitated by the relative lack of tech-
nical difficulties (e.g. the membrane hardly ever gets
clogged by these drugs). The main arguments men-
tioned by this population for the continued use of cot-
ton filters are the conservation and re-use of “old
cottons” and the assumption that filtration of these
drugs is less important than filtration of
pharmaceuticals.
Finally, morphine sulphate capsules are almost always
filtered using either cotton or cigarette filters (only 11%
used an IDUSF), despite of the higher frequency of “bad
hits” found to be related to their injection. This prefer-
ence is due to the preparation method generally used to
dissolve the morphine sulphate, which involves heating
the solution before filtration, making it viscous so that
even the cotton filter can be too dense to filter it.
For those who use other filters, the majority use the
sterile cotton to filter buprenorphine, cocaine and her-
oin, while morphine sulphate injectors generally prefer a
cigarette filter.
Substantial differences have been found between cities
for filter preference, suggesting that local community
practices may have a significant effect on filter prefer-
ence (Figure 1). This is consistent with several studies
which have described the importance of peer influence
on drug use [15,20,21].
For buprenorphine, the cultural influence on filter
preference did not show significant differences between
cities (p = 0.1). These differences were quite large
though (74% of the buprenorphine users in Beziers use
a syringe filter, compared to only 40% in Paris), suggest-
ing that the sample size might have been too low to
obtain significance. Local filter preference differences
are significant for the injection of heroin (3 levels, p <
0.0001), cocaine (3 levels, p < 0.001), and morphine sul-
phate (2 levels, p = 0.05).
Besides these factors, the questionnaires and focus
groups revealed IDUs rationales for the preference of
one filtration method over another.
Reasons for not using a syringe filter
Most of the reasons brought up for the use of “other fil-
ters” concerned technical difficulties linked to the use of
the Sterifilt®. Scott [13] had also observed that some
IDUs find the Sterifilt® difficult to use. Here, we explore
which types of barriers are encountered.
Several participants mentioned that the membrane can
become clogged, which is attributable to its small pore
size, combined with a high density and insoluble particle
content of the solution. Membrane obstruction is thus
more frequent with pill injection and particularly with
the injection of morphine sulphate. This is due to the
method used to prepare Skénan® for injection: capsules
Table 2 The drugs injected by participants









Morphine Sulphate (Skénan®) 39% 15%
Other 22% 6%
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are opened and the contained microbeads are crushed,
water is added and the solution heated. Due to the gela-
tine contained in these microbeads, the process of heat-
ing produces a dense solution which clogs the filtering
membrane. A participant of the Focus group in Tou-
louse illustrates this very well:
“I inject morphine sulphate every day (...). In the
beginning, I heated to solution. I thus used a cotton
filter, or more often a cigarette filter, because it was
difficult. I used a very small piece of cigarette filter,
the smallest possible, otherwise it wouldn’t get
through.”(male, age 26)
Preparation and filtration using a syringe filter can be
slow. This can be an obstacle at two distinct moments:
When fitting the filter to the syringe, which takes
some training and concentration.
“For me it’s the speed, not the speed of filtration,
which I believe is fast, but to fit the filter to the syr-
inge. (...) I go through a lot of trouble, especially
when I have used a lot (of drugs) or when I shiver
(...). You have to be very concentrated to fit the Steri-
filt to the syringe”. (male, age 41)
When pulling up the plunger. Due to the small pore
size, it takes some time for the solution to get
through.
“I don’t use the Sterifilt often. Filtration is slow and
takes too much time. When I don’t have the time, I
don’t filter at all” (female, age 33)
The Sterifilt® might damage the needle. If a person is
in a hurry, under the influence of drugs or in withdra-
wal while fitting the Sterifilt® to the syringe, he or she
might lack the concentration needed to perform this
operation. The needle might then touch the plastic of
the filter and thus get damaged.
“When I use a Sterifilt, I often damage a needle. As I
don’t use drugs regularly, to limit my consumption, I
only take two syringes when I plan to use. If I then
damage the needle, I don’t have spare needles. I thus
prefer using a cotton filter.” (male, age 36)
Related to these technical difficulties is the fact that
IDUs don’t always have the time, though some spoke
about patience, to use this filter; especially if they are
stressed or if they prepare their injection in a mala-
dapted environment (public toilets, street).
“Filtration also depends on the context. Even though
you always filter as you should, this is impossible if
you have to inject in public toilets.”(male, age 35)

Figure 1 Frequent Stérifilt® use during the last month per city in relation to the drugs injected. The percentage of IDUs who frequently
("always” or “frequent”) use the Sterifilt for each of the four most commonly used drugs in 9 different French cities.
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It is interesting to note that the information from the
field, which suggests that the Sterifilt® is more readily
adopted by IDUs who have stable living conditions than
by those who live and use in the street, cannot be con-
firmed by the quantitative data. Though several partici-
pants, as here above, stated that some contexts are indeed
less adapted than others, no correlation has been found
between precarious living conditions and Sterifilt® use.
As the use of a syringe filter changes the drug pre-
paration ritual, for some, there never seems to be an
appropriate moment to try out a new technique or tool.
The perseverance of existing injecting practices can thus
be a second major barrier to the use of syringe filters.
Several presumptions about current practices may act
as a barrier to syringe filter use, such as the idea that
someone’s current filtration technique is efficient in elim-
inating particles, or that some drugs don’t need filtration
because no insoluble particles are visible in the solution.
However, clear solutions are not always free of them, as
some potentially harmful insoluble particles are invisible
to the naked eye [22]. Cocaine and heroin filtration was
believed to be of less importance because of the absence
of tablet fillers such as starch and talc, and due to the
lower prevalence of complications at the injection site (in
France, complications at the injection site are more pre-
valent among buprenorphine users [19]).
“I only use the Sterifilt when my coke is very filthy”
(male, age 39)
Others presume that the Sterifilt® is only meant for
frequent injectors, a presumption reflected by the fact
that frequent injectors use this filter more often.
“I don’t use the Sterifilt often. I know it is better, but
I don’t use drugs often, not daily. It is important for
guys who inject every day” (male, age 36)
Furthermore, some IDUs who inject an opaque solu-
tion for years can experience considerable difficulties
admitting that their drug is completely water-soluble
and that a transparent solution thus contains the same
amount of active compound.
“The cotton is more efficient, for the solution is white”
(female, age 25)
Additionally, similar to the findings of Scott [13],
IDUSF’s low drug retention can be considered as a dis-
advantage. Several respondents reported retaining cotton
filters as a means to keep a small amount of drug “for
later” and did not wish to change this behaviour. This
conservation and reuse of cottons was associated with
the injection of heroin, morphine sulphate and cocaine.
These drugs are difficult to obtain and expensive; their
consumption can be compulsive and/or shortage can
readily induce withdrawal. Reuse of cottons was rarely
mentioned by buprenorphine users.
“I always used the Sterifilt solely for Subutex (bupre-
norphine) (...). For heroin and cocaine, I had that old
“craze” to use a cotton and keep it (...). I did it all:
squeeze the last drop out of the filter using my
hands, everything.” (female, age 32)
A final barrier to the use of IDUSF was that they are
not readily available everywhere. Though virtually all
NEPs in France give them out, they are not accessible at
syringe vendor machines or at pharmacies where 60 to
80% of all syringes are exchanged [23,24]. This excludes
IDUs who do not visit NEPs from being familiar with
this filter, and influences its acceptance and habituation
by other IDUs, as they do not have access to it at each
time they exchange syringes.
“New injectors don’t go to needle exchange programs
(...). Habits from the beginning persist; Sterifilt should
be given to new ones” (male, age 36)
Reasons for using a syringe filter
The two main arguments reported by IDUs for using
the Sterifilt® are the quality of filtration and more gen-
erally the role of this filter in the prevention of health
problems.
Participants reported that solutions filtered by this
IDUSF contained less “chunks”, were cleaner and
clearer. Buprenorphine users were particularly likely to
describe these as advantages of syringe filters. Addition-
ally, buprenorphine users mention specifically the
removal of starch as an advantage of syringe filters.
“Less deposit, less starch, cleaner” (male, age 30)
Secondly, similar to the findings of Scott [13], partici-
pants either state that they believe the Sterifilt® reduces
drug related harm or that they have actually experienced
a reduction in complications such as abscesses, bad hits,
and phlebitis.
“I’ve had a phlebitis, that’s the reason why I adopted
the Sterifilt. Since, I don’t have “pins and needles in
my legs” anymore, less abscesses and no more phlebi-
tis” (male, age 36)
Respondents also refer to the capacity of this filter to
preserve the injection site. They state that when the
solution is unintentionally injected into the soft tissue
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surrounding the vein, complications are less harmful
and of a shorter duration.
“I use the Sterifilt to get rid of particles. When I miss
my hit (the expression “a missed hit” refers to the
deposit of the solution outside the vein), I don’t have
any abscesses any more” (male, age 48)
Furthermore, veins are described to recover more
quickly when a syringe filter is used.
“Veins recover when you use the Sterifilt. You can’t
use it (the vein) for a couple of days, but after that,
you can reuse it” (male, age 39)
This may be due to the reduction in the number of
large insoluble particles in the solution and/or to the
protection of the needle by the filter when it is appro-
priately fitted to the syringe. Indeed, this syringe filter
covers the needle completely and thus prevents it from
touching the inside of the cooker.
Most Sterifilt® users consider its low drug retention as
positive: they gain a better high because there is virtually
no loss of active compound. This characteristic can also
serve a protective role, removing the temptation to keep fil-
ters for later. Indeed, for some, even though they are aware
of the risks and do not want to reuse filters, it is difficult to
throw away a filter containing 6 to 13% of the active com-
pound. This tendency was also described by Scott [13].
“You gain in active product and you won’t do the
cotton” (male, age 26)
Finally, several people familiar with its use described
the Sterifilt® as easy and quick to use.
It is interesting to note that IDUs never mentioned
the prevention of hepatitis C transmission through the
reduction of reuse and sharing as a reason for IDUSF
use. It seems that, for individual users, local complica-
tions and vein damage are of more immediate concern,
as they occur almost instantly after injection. As for pul-
monary complications, most people are unaware of the
link between injecting drug use, filtration methods and
pulmonary problems, and may impute respiratory diffi-
culties to infections or tobacco use.
Conclusion
IDUSF and other commercial syringe filters have the
capacity to considerably reduce harms associated with
injecting drug use, such as complications at the injection
site, and pulmonary problems due to the injection of
insoluble particles, but also hepatitis C transmission
through the reduction of reuse and sharing of filters due
to their reduced drug retention. Several studies [13,14]
have evaluated the efficacy of IDUSF or wheel filters.
Scott’s research [13] also included some questions on
filter preference. However, to our knowledge, this is the
first study exploring the factors and reasons for filter
preference among injecting drug users in detail. A better
understanding of factors and IDUs’ motives influencing
filter choice may help drug workers to promote the use
of less harmful filters. The unique French situation of
high availability of IDUSF and sterile cotton filters cre-
ates the opportunity to study these factors.
The results show three main factors influencing the
filter of choice:
Individual drug users have the tendency to generalise
their preparation method to all drugs used. Additionally,
people who started injecting when the IDUSF filter
already was available, use it more often, as do people
who inject frequently.
The drugs injected. Three categories can be distin-
guished amongst the four drugs most commonly
injected:
The majority of the buprenorphine injectors (64%)
used an IDUSF during their last injection, mainly to
reduce the frequent complications at the injection site
related to the injection of this drug.
39% of the heroin users and 33% of the cocaine users
used the syringe filter to preserve their health. The cot-
ton filter on the other hand, is often preferred for it
allows “keeping some for later” in order to prevent with-
drawal; furthermore, fine filtration of these drugs is
often considered less important.
Only 11% of the people injecting morphine sulphate
used this filter, due to frequent technical difficulties, like
membrane obstruction, which is, in its turn, related to
the preparation method used for this drug.
Subculture and peer influence on preparation- and
harm reduction techniques were confirmed by a varia-
tion in local filter preference.
These three factors suggest that positive change is
possible: influence of the individual and subculture, as
well as the relatively slow but stable progression of syr-
inge filter use, suggest that these behaviours can poten-
tially be changed.
Harm minimization information will probably be more
efficient if it addresses the advantages perceived by IDUs.
Once understood, technical difficulties may become rela-
tively less important. This study shows that the reduction
of complications at the injection site is perceived as the
main advantage of syringe filters. The transparency of the
solution, the reductions of abscesses and cellulites, as
well as the preservation of veins are often referred to by
drug users. The gain in active compound due to low drug
retention also seems to be an important issue which, in
addition, can be used as a protective mechanism against
the re-use and sharing of filters.
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However, barriers remain for some users. It is neces-
sary to acquire the technique to use this type of filter,
filtration is relatively slow and the filter membrane may
be clogged by cutting agents and tablet fillers. It is thus
important for needle exchange programs to provide fre-
quent demonstrations, accompanied by the diffusion of
appropriate information and prevention messages on the
solubility of drugs and the harms associated to the injec-
tion of insoluble particles. The provision of information
has been effective in France, where information flow
was concentrated on buprenorphine use; the majority of
its users have adopted the IDUSF. Increased availability
would probably also enhance IDUSF use.
Previous research has shown that drug users are pre-
occupied by their health and willing to change their
behaviour. To change preparation and filtration techni-
ques, information should be concentrated on the per-
ceived advantages of new techniques; these will be more
convincing and able to promote change.
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